TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $46,000 | +17.9% | 34,166 | -1.7% | 0.00% | – |
Q4 2018 | $39,000 | -59.8% | 34,768 | -0.8% | 0.00% | – |
Q3 2018 | $97,000 | -19.2% | 35,035 | +4.3% | 0.00% | – |
Q2 2018 | $120,000 | +18.8% | 33,604 | +2.2% | 0.00% | – |
Q1 2018 | $101,000 | -53.2% | 32,892 | -4.1% | 0.00% | -100.0% |
Q4 2017 | $216,000 | -6.5% | 34,298 | +1.4% | 0.00% | 0.0% |
Q3 2017 | $231,000 | +38.3% | 33,826 | +44.1% | 0.00% | 0.0% |
Q2 2017 | $167,000 | -18.9% | 23,481 | +4.9% | 0.00% | 0.0% |
Q1 2017 | $206,000 | +145.2% | 22,390 | +7.1% | 0.00% | – |
Q4 2016 | $84,000 | -99.9% | 20,904 | -0.3% | 0.00% | – |
Q3 2016 | $80,269,000 | -10.8% | 20,958 | +0.2% | 0.00% | – |
Q2 2016 | $89,982,000 | -13.5% | 20,926 | -7.0% | 0.00% | – |
Q1 2016 | $104,000,000 | -53.8% | 22,495 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $225,000,000 | +133828.6% | 22,495 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $168,000 | -100.0% | 22,532 | +0.1% | 0.00% | -75.0% |
Q2 2015 | $1,067,732,000 | +64.3% | 22,507 | +26.9% | 0.00% | +33.3% |
Q1 2015 | $649,774,000 | -7.7% | 17,734 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $704,217,000 | +129.0% | 17,734 | +15.1% | 0.00% | +200.0% |
Q3 2014 | $307,469,000 | +47.8% | 15,412 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $208,056,000 | +100.3% | 15,423 | +61.7% | 0.00% | – |
Q1 2014 | $103,869,000 | -17.5% | 9,538 | +2.5% | 0.00% | -100.0% |
Q4 2013 | $125,858,000 | +43.2% | 9,309 | +20.6% | 0.00% | – |
Q3 2013 | $87,865,000 | – | 7,721 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |